Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development
- Naomi Berrie Diabetes Institute, Columbia University Medical School, Columbia
- Columbia University Medical School, Columbia
- Barbara Davis Center, University of Colorado, United States
Figures
Figure 1 with 1 supplement
Nkx2.2 is ablated specifically in the endocrine lineage in Nkx2.2△endo mice.
(A) Nkx2.2 gene expression is decreased at E15.5 (Control n = 3, Nkx2.2△endo n = 6) and E18.5 (Control n = 6, Nkx2.2△endo n = 4). (B–C) Immunostaining for Nkx2.2 shows decreased expression in Nkx2.2△…
Figure 1—figure supplement 1
Exocrine and endocrine compartment size is unaffected Nkx2.2△endo mice.
(A–B) Immunostaining for Neurog3 shows no change in Neurog3+ cell number; (C–D) adjacent sections show decreased Nkx2.2+ cells in Nkx2.2△endo embryos at E15.5. (E–F) Immunostaining for Nkx2.2 shows …
Figure 2 with 2 supplements
Nkx2.2△endo mice recapitulate the Nkx2.2KO phenotype.
(A–H) Ghrl+ cells are increased, Ins+ cells are greatly reduced, and Gcg+ cells are decreased at E15.5 and P0 in Nkx2.2△endo mice (n = 3). (I–J) Gast+ cells are reduced in Nkx2.2△endo embryos at …
Figure 2—figure supplement 1
Nkx2.2△endo mice display endocrine specification defects at P0.
(A–D) Low magnification images showing increased Ghrl+ cells, and decreased Ins+ cells and Gcg+ cells in Nkx2.2△endo mice at P0 (n = 3). (E) Whole pancreas quantification of Gcg+, Sst+, and Ghrl+ …
Figure 2—figure supplement 2
PP cells are increased in Nkx2.2△endo mice.
(A–D) Immunostaining for PP shows increased PP+ cells at E15.5 and P0 in Nkx2.2△endo mice (n = 3). Arrow indicates a PP+Ins+ cell. (E–F) Low magnification images showing increased PP+ cells at P0 in …
Figure 3 with 1 supplement
Nkx2.2△endo and Nkx2.2KO embryos have shared and distinct gene expression changes.
(A) Comparison of Nkx2.2△endo and Nkx2.2KO RNA-Seq experiments shows significant overlap of dysregulated genes (adjusted p-value <0.05.) (B) RNA-Seq reveals similar changes in hormone expression in N…
-
Figure 3—source data 1
Nkx2.2△endo and Nkx2.2KO E15.5 RNA-Seq: Genes showing significant differential expression in both Nkx2.2△endo and Nkx2.2KO mice (120 genes).
- https://doi.org/10.7554/eLife.20010.009
-
Figure 3—source data 2
Nkx2.2△endo and Nkx2.2KO E15.5 RNA-Seq: Genes showing significant differential expression in only Nkx2.2KO mice (325 genes).
- https://doi.org/10.7554/eLife.20010.010
-
Figure 3—source data 3
Nkx2.2△endo and Nkx2.2KO E15.5 RNA-Seq: Genes showing significantly differential expression in only Nkx2.2△endo mice (55 genes).
- https://doi.org/10.7554/eLife.20010.011
Figure 3—figure supplement 1
Many islet transcription factor genes are relatively unchanged in Nkx2.2deltaendo embryos.
(A) RNA-Seq at E15.5 shows no changes in Nkx6.1, Pax4, or Pdx1 gene expression in Nkx2.2△endo and Nkx2.2KO embryos, relative to respective littermate controls; dotted line refers to 1.0 fold change. …
Figure 4
Nkx2.2 bound and regulated genes are co-bound by Rfx6 and Neurod1.
(A) Comparison of Nkx2.2 bound and regulated genes and Rfx6 bound genes (B) Gene ontology (GO) analysis of genes with Nkx2.2 binding and regulation and Rfx6 binding. (C) Comparison of Nkx2.2 bound …
-
Figure 4—source data 1
Nkx2.2 bound and regulated genes that are also Rfx6 bound (120 genes) or NeuroD1 bound (92 genes).
- https://doi.org/10.7554/eLife.20010.014
-
Figure 4—source data 2
Nkx2.2 bound and regulated genes that are also Rfx6 bound and NeuroD1 bound (72 genes).
- https://doi.org/10.7554/eLife.20010.015
Figure 5
Model of transcriptional networks involved in endocrine cell specification in wildtype (WT), Nkx2.2KO, and Nkx2.2△endo conditions.
Neurog3, Neurod1, and Rfx6 are not sufficient to allow for β cell specification in the absence of Nkx2.2 in Nkx2.2△endo mice. The size of the circles represents the proportion of cell numbers …
Tables
Table 1
NKx2.2Δendo and Nkx2.2KO E15.5 RNA-Seq - Gene expression changes in select transcription factors and pancreatic hormones.
Nkx2.2△endo fold change | Adjusted p-value | Nkx2.2KO fold change | Adjusted p-value | |
|---|---|---|---|---|
Transcription factors | ||||
Arx | 2.16 | 3.26E-09 | 1.57 | 0.0031 |
MafA | 0.11 | 3.39E-06 | 0.13 | 0.0040 |
MafB | 0.43 | 1.31E-10 | 0.22 | 3.92E-38 |
NeuroD1 | 0.89 | 1 | 0.32 | 3.01E-23 |
Neurog3 | 1.11 | 1 | 0.59 | 0.0198 |
Nkx6.1 | 0.77 | 1 | 0.82 | 0.9684 |
Pax4 | 1.02 | 1 | 0.73 | 0.4762 |
Pax6 | 0.36 | 1.07E-06 | 0.21 | 2.84E-30 |
Pdx1 | 0.88 | 1 | 1.25 | 0.7916 |
Rfx6 | 1.00 | 1 | 0.63 | 0.0013 |
Sox9 | 0.94 | 1 | 1.08 | 1 |
Pancreatic hormones | ||||
Gast | 0.19 | 2.16E-07 | 0.09 | 2.63E-09 |
Gcg | 0.16 | 2.23E-12 | 0.01 | 4.64E-16 |
Ghrl | 8.27 | 1.94E-31 | 6.43 | 6.72E-16 |
Ins1 | 0.03 | 4.84E-24 | 0.00 | 4.32E-11 |
Ins2 | 0.01 | 2.99E-55 | 0.00 | 1.48E-11 |
Ppy | 10.08 | 4.99E-42 | 2.17 | 7.15E-05 |
Sst | 1.14 | 1 | 0.45 | 0.5130 |
